High on innovation, rising demand and rejuvenated confidence to translate opportunities into success, the Indian pharmaceutical industry, which is among the top three in terms of volume globally, is growing leaps and bounds. By an estimate, the industry is all set to expand at a Compound Annual Growth Rate (CAGR) of 16 per cent to $55 billion by 2020. Much of this growth will depend on Indian pharma companies’ capacity to adopt Information Technology to drive their productivity, improve efficiency and maintain cost effectiveness.

In view of increased digital adoption, it is expected that Healthcare Information Technology (IT) market would expand more than 1.5 times by 2020 from its current value of $1 billion to meet the demand from pharma industry as well as other vertical of the healthcare sector….[Read More]


Future Pharma For One World! Be a Global Leader in the Pharma

Past Partners in our Summits

eHealth 2016 Conferences Videos

Social Footprints

Facebook Likes
Linkedin Followers
Twitter Followers
Our Conferences

Powered By

RSS Latest on eHEALTH Pharma

  • Suven secures product patents in India, Japan
    Hyderabad-based Suven Life Sciences has announced that the biopharmaceutical company has secured the grant of one product patent each from India (285812) and Japan (6185650) related to the New Chemical Entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases. According to the company, these patents are valid through 2027 and 2032 respectively. “We […]
  • Fosun to buy 74% stake in Gland Pharma
    Shanghai Fosun Pharmaceutical Group Co. Ltd, a unit of China’s Fosun Group has agreed to acquire 74 percent  of Indian drug company Gland Pharma Ltd for $1.1 billion. Fosun Pharma had struck a deal in July last year to buy an 86 percent stake valued at about $1.26 billion in the Indian generic injectable drugmaker. […]
  • Health Ministry launches two new contraceptives
    The Ministry of Health and Family Welfare has launched two new contraceptives, an injectable contraceptive MPA under the ‘Antara’ programme and a contraceptive pill, ‘Chhaya’, to meet the emerging needs of couples. The contraceptives, which are currently available for free in medical colleges and district hospitals, have been launched in 10 states including Maharashtra, Uttar […]
  • Ajanta Pharma gets USFDA nod to market Parkinson’s disease drug
    Mumbai-based pharmaceutical company Ajanta Pharma Limited has received the final approval from US Food and Drug Administration (USFDA) to market Entacapone tablets in 200 mg strength, which is indicated for the treatment of Parkinson’s disease symptoms. Entacapone is a bioequivalent generic version of Comtan tablets produced by Novartis Pharmaceuticals Corporation. Ajanta will be launching the […]
  • Zydus receives USFDA nod for dementia drug
    Pharmaceutical major Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Donepezil Hydrochloride tablets in the country, a drug used for the treatment of dementia associated with the Alzheimer’s disease. According to the company, the drug will be manufactured at its facility in Moraiya, Ahmedabad. Alzheimer’s is a […]

Know More About Pharma CIO 2017